Page last updated: 2024-12-11

pederin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pederin: isolated from beetles, Paederus fuscipes; minor descriptor (75-84); on-line & Index Medicus search PYRANS (75-84); RN given refers to (2S-(2alpha(R*(R*(2S*,5S*,6S*))),4beta,6beta(R*)))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pederin : A polyketide and carboxamide produced by a (Pseudomonas) bacterial endosymbiont of certain rove beetles (genus Paederus). Pederin is the agent responsible for the vesicant effects (linear or Paederus dermatitis) when the beetle is crushed against the skin. It is a powerful inhibitor of protein biosynthesis and mitosis and a potent antitumour agent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5381287
CHEBI ID78591
SCHEMBL ID452974
MeSH IDM0262743

Synonyms (24)

Synonym
2h-pyran-2-acetamide, n-(6-(2,3-dimethoxypropyl)tetrahydro-4-hydroxy-5,5-dimethyl-2h-pyran-2-yl)tetrahydro-alpha-hydroxy-2-methoxy-5,6-dimethyl-4-methylene-, (2s-(2alpha(r*(r* (2s*,5s*,6s*))),4beta,6beta(r*)))-
2h-pyran-2-glycolamide, n-((6-(2,3-dimethoxypropyl)tetrahydro-4-hydroxy-5,5-dimethyl-2h-pyran-2-yl)methoxymethyl)tetrahydro-2-methoxy-5,6-dimethyl-4-methylene-
d-manno-nonitol, 2,6-anhydro-3,5,7-trideoxy-1-c-(((2s)-hydroxy((2r,5r,6r)-tetrahydro-2-methoxy-5,6-dimethyl-4-methylene-2h-pyran-2-yl)acetyl)amino)-5,5-dimethyl-1,8,9-tri-o-methyl-, (1s)-
nsc 114781
2h-puran-2-acetamide,3-dimethoxypropyl)tetrahydro-4-hydroxy-5,5- dimethyl-2h-pyran-2-yl]tetrahydro-.alpha.-hydroxy-2- methoxy-5,6-dimethyl-4-methylene-, [2s-[2.alpha.[r*[r* (2s*,5s*,6s*)]],4.beta.,6.beta.(r*)]]-
nsc-114781
pederine
2h-pyran-2-glycolamide,3-dimethoxypropyl0tetrahydro-3-hydroxy-5,5- dimethyl-2h-pyran-2-yl]methoxymethyl]tetrahydro-2-methoxy- 5,6-dimethyl-4-methylene-
27973-72-4
pederin
(2s)-n-[(s)-[(2s,4r,6r)-6-[(2s)-2,3-dimethoxypropyl]-4-hydroxy-5,5-dimethyloxan-2-yl]-methoxymethyl]-2-hydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
b8f7j348gj ,
unii-b8f7j348gj
SCHEMBL452974
pederin, (+)-
(+)-pederin
pederin [mi]
d-manno-nonitol, 2,6-anhydro-3,5,7-trideoxy-1-c-(((2s)-2-hydroxy-2-((2r,5r,6r)-tetrahydro-2-methoxy-5,6-dimethyl-4-methylene-2h-pyran-2-yl)acetyl)amino)-5,5-dimethyl-1,8,9-tri-o-methyl-, (1s)-
(+)-pederine
paederine
CHEBI:78591
(2s)-n-[(s)-{(2s,4r,6r)-6-[(2s)-2,3-dimethoxypropyl]-4-hydroxy-5,5-dimethyltetrahydro-2h-pyran-2-yl}(methoxy)methyl]-2-hydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylenetetrahydro-2h-pyran-2-yl]acetamide
DTXSID90182248
Q8214251
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
vesicantAny compound that causes severe skin, eye and mucosal pain and irritation.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antimitoticAny compound that inhibits cell division (mitosis).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
polyketideNatural and synthetic compounds containing alternating carbonyl and methylene groups ('beta-polyketones'), biogenetically derived from repeated condensation of acetyl coenzyme A (via malonyl coenzyme A), and usually the compounds derived from them by further condensations, etc. Considered by many to be synonymous with the less frequently used terms acetogenins and ketides.
cyclic ketalA ketal in the molecule of which the ketal carbon and one or both oxygen atoms thereon are members of a ring.
diolA compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols.
oxanesAny organic heteromonocyclic compoundthat is oxane or its substituted derivatives.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.00)18.7374
1990's8 (16.00)18.2507
2000's18 (36.00)29.6817
2010's19 (38.00)24.3611
2020's4 (8.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.38 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index62.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (13.46%)6.00%
Case Studies7 (13.46%)4.05%
Observational0 (0.00%)0.25%
Other38 (73.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]